Jacques Massol

Summary

Country: France

Publications

  1. pmc Benchmarking clinical management of spinal and non-spinal disorders using quality of life: results from the EPI3-LASER survey in primary care
    Michel Rossignol
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 4820 Boulevard Saint Laurent, Montreal, QC H2T 1R5, Canada
    Eur Spine J 20:2210-6. 2011
  2. pmc Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France
    Michel Rossignol
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada and LA SER Centre for Risk Research, Montreal, Canada
    BMC Musculoskelet Disord 12:21. 2011
  3. doi request reprint [How should one anticipate the assessment of the public health benefit of new medicines?]
    Jacques Massol
    Institut Phisquare, Fondation Transplantation, Besancon, France
    Therapie 62:417-25. 2007
  4. doi request reprint How to anticipate the assessment of the public health benefit of new medicines?
    Jacques Massol
    Phisquare Institute, The Foundation Transplantation, Besancon, France
    Therapie 62:427-35. 2007
  5. ncbi request reprint Use of the foreign studies: transposition of the results, prediction of the therapeutic effects in the french population, modelling of the public health interest
    Jacques Massol
    Centre Hospitalo Universitaire de Besançon, Hopital Saint Jacques, Besancon, France
    Therapie 61:481-9, 491-9. 2006
  6. ncbi request reprint Infliximab continuation rates in patients with rheumatoid arthritis in everyday practice
    Daniel Wendling
    Rheumatology Department, Minjoz Teaching Hospital, CHU Minjoz, 25030 Besancon, France
    Joint Bone Spine 72:309-12. 2005
  7. ncbi request reprint [Evaluation of drug efficacy]
    Jacques Massol
    Faculté de Médecine de Besançon, Hopital Jean Minjoz, Besancon
    Presse Med 36:505-11. 2007
  8. ncbi request reprint Asthmatic patients' poor awareness of inadequate disease control: a pharmacy-based survey
    Laurent Laforest
    Universite de Lyon, France
    Ann Allergy Asthma Immunol 98:146-52. 2007
  9. doi request reprint Non-interventional research and usual care: definition, regulatory aspects, difficulties and recommendations
    Francois Lemaire
    Medical Intensive Care, Henri Mondor Hospital, Creteil, France
    Therapie 63:103-6, 97-101. 2008

Collaborators

Detail Information

Publications9

  1. pmc Benchmarking clinical management of spinal and non-spinal disorders using quality of life: results from the EPI3-LASER survey in primary care
    Michel Rossignol
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 4820 Boulevard Saint Laurent, Montreal, QC H2T 1R5, Canada
    Eur Spine J 20:2210-6. 2011
    ..001). In conclusion, anxiety and depressive disorders were commonly reported by GPs among chronic MSD patients. Their prescriptions of psychotropic and analgesic drugs were consistent with patients' self-rated mental and physical health...
  2. pmc Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France
    Michel Rossignol
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada and LA SER Centre for Risk Research, Montreal, Canada
    BMC Musculoskelet Disord 12:21. 2011
    ....
  3. doi request reprint [How should one anticipate the assessment of the public health benefit of new medicines?]
    Jacques Massol
    Institut Phisquare, Fondation Transplantation, Besancon, France
    Therapie 62:417-25. 2007
  4. doi request reprint How to anticipate the assessment of the public health benefit of new medicines?
    Jacques Massol
    Phisquare Institute, The Foundation Transplantation, Besancon, France
    Therapie 62:427-35. 2007
    ..Finally, because of the PHB's universal dimension, it is suggested that the necessary actions and publications be initiated so that the PHB can be acknowledged at the European level...
  5. ncbi request reprint Use of the foreign studies: transposition of the results, prediction of the therapeutic effects in the french population, modelling of the public health interest
    Jacques Massol
    Centre Hospitalo Universitaire de Besançon, Hopital Saint Jacques, Besancon, France
    Therapie 61:481-9, 491-9. 2006
    ....
  6. ncbi request reprint Infliximab continuation rates in patients with rheumatoid arthritis in everyday practice
    Daniel Wendling
    Rheumatology Department, Minjoz Teaching Hospital, CHU Minjoz, 25030 Besancon, France
    Joint Bone Spine 72:309-12. 2005
    ..Infliximab is a major breakthrough in the management of rheumatoid arthritis (RA). We evaluated infliximab continuation rates and reasons for discontinuation in patients with RA...
  7. ncbi request reprint [Evaluation of drug efficacy]
    Jacques Massol
    Faculté de Médecine de Besançon, Hopital Jean Minjoz, Besancon
    Presse Med 36:505-11. 2007
    ..This score also helps the drug economics committee determine a price for the drug (improvement of the expected medical service)...
  8. ncbi request reprint Asthmatic patients' poor awareness of inadequate disease control: a pharmacy-based survey
    Laurent Laforest
    Universite de Lyon, France
    Ann Allergy Asthma Immunol 98:146-52. 2007
    ..Many asthmatic patients fail to perceive their level of disease control...
  9. doi request reprint Non-interventional research and usual care: definition, regulatory aspects, difficulties and recommendations
    Francois Lemaire
    Medical Intensive Care, Henri Mondor Hospital, Creteil, France
    Therapie 63:103-6, 97-101. 2008
    ....